BCI
REGN icon

Brinker Capital Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Brinker Capital Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Sell
1,761
-52
-3% -$39.8K 0.01% 949
2025
Q4 		$1.4M Sell
1,813
-90
-5% -$61.1K 0.01% 1049
2025
Q3 		$1.07M Buy
1,903
+399
+27% +$226K 0.01% 1190
2025
Q2 		$789K Sell
1,504
-326
-18% -$182K 0.01% 1318
2025
Q1 		$1.16M Sell
1,830
-252
-12% -$173K 0.01% 1002
2024
Q4 		$1.48M Sell
2,082
-489
-19% -$410K 0.01% 842
2024
Q3 		$2.7M Sell
2,571
-302
-11% -$336K 0.03% 542
2024
Q2 		$3.02M Buy
2,873
+138
+5% +$134K 0.03% 473
2024
Q1 		$2.63M Sell
2,735
-36
-1% -$34.2K 0.03% 528
2023
Q4 		$2.5M Sell
2,771
-12,934
-82% -$10.7M 0.03% 534
2023
Q3 		$12.9M Sell
15,705
-1,109
-7% -$872K 0.16% 138
2023
Q2 		$12.1M Sell
16,814
-458
-3% -$353K 0.13% 153
2023
Q1 		$14.2M Buy
17,272
+1,395
+9% +$1.05M 0.18% 122
2022
Q4 		$11.5M Sell
15,877
-4,121
-21% -$3.04M 0.23% 100
2022
Q3 		$13.8M Sell
19,998
-484
-2% -$305K 0.28% 82
2022
Q2 		$12.1M Sell
20,482
-179
-0.9% -$116K 0.23% 96
2022
Q1 		$14.4M Sell
20,661
-5,492
-21% -$3.47M 0.22% 101
2021
Q4 		$16.5M Sell
26,153
-8,011
-23% -$4.93M 0.24% 84
2021
Q3 		$19.1M Buy
34,164
+768
+2% +$477K 0.3% 74
2021
Q2 		$18.7M Buy
33,396
+5,741
+21% +$2.91M 0.25% 98
2021
Q1 		$13.1M Buy
+27,655
New +$13.5M 0.2% 126
2020
Q4 		– Sell
-13,676
Closed -$7.66M – 1162
2020
Q3 		$7.66M Buy
+13,676
New +$8.29M 0.13% 177
2020
Q1 		– Sell
-3
Closed -$1K – 649
2019
Q4 		$1K Buy
+3
New +$1.01K ﹤0.01% 782

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Brinker Capital Investments's REGN Position: Q1 2026 in Review

Brinker Capital Investments reduced its Regeneron Pharmaceuticals (REGN) stake by 2.9% in Q1 2026, selling an estimated $39.8K and leaving 1,761 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #949.

Brinker Capital Investments first reported a position in REGN in Q4 2019 and has held it in 23 quarters since. The position peaked at $19.1M in Q3 2021. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Brinker Capital Investments held 1,761 shares of Regeneron Pharmaceuticals worth $1.36M as of Q1 2026.
  • Brinker Capital Investments sold 52 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $39.8K.
  • Regeneron Pharmaceuticals made up 0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #949 holding.
  • Brinker Capital Investments first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 23 quarters since.
  • Brinker Capital Investments's Regeneron Pharmaceuticals position peaked at $19.1M in Q3 2021.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.